MACRO Consulting Group’s Quest Diagnostics DGX Stock Holding History

MACRO Consulting Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$2.19M	Sell	16,612 -563	-3%	-$73.7K	1.13%	30
2021 Q1	$2.2M	Sell	17,175 -93	-0.5%	-$11.5K	1.19%	23
2020 Q4	$2.06M	Buy	17,268 +36	+0.2%	+$4.39K	1.19%	24
2020 Q3	$2.1M	Sell	17,232 -521	-3%	-$61.6K	1.38%	18
2020 Q2	$2.02M	Sell	17,753 -251	-1%	-$26.6K	1.4%	15
2020 Q1	$1.94M	Buy	18,004 +361	+2%	+$37.4K	1.49%	16
2019 Q4	$1.89M	Buy	17,643 +693	+4%	+$72.3K	1.49%	24
2019 Q3	$1.82M	Buy	16,950 +209	+1%	+$21.5K	1.55%	17
2019 Q2	$1.7M	Buy	16,741 +788	+5%	+$75.7K	1.46%	23
2019 Q1	$1.44M	Buy	15,953 +776	+5%	+$67.2K	1.38%	37
2018 Q4	$1.27M	Buy	+15,177	New	+$1.42M	1.24%	37

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

MACRO Consulting Group's DGX Position: Q2 2021 in Review

MACRO Consulting Group reduced its Quest Diagnostics (DGX) stake by 3.3% in Q2 2021, selling an estimated $73.7K and leaving 16,612 shares worth $2.19M. The position accounts for 1.13% of the portfolio, ranked #30.

MACRO Consulting Group first reported a position in DGX in Q4 2018 and has held it in 11 quarters since. The position peaked at $2.2M in Q1 2021. 815 funds tracked by Wall St. Rank hold DGX as of Q2 2021.

MACRO Consulting Group held 16,612 shares of Quest Diagnostics worth $2.19M as of Q2 2021.
MACRO Consulting Group sold 563 Quest Diagnostics shares in Q2 2021, an estimated $73.7K.
Quest Diagnostics made up 1.13% of MACRO Consulting Group's portfolio in Q2 2021, its #30 holding.
MACRO Consulting Group first reported a position in Quest Diagnostics in Q4 2018 and has held it in 11 quarters since.
MACRO Consulting Group's Quest Diagnostics position peaked at $2.2M in Q1 2021.
815 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2021.

Based on MACRO Consulting Group's 13F filing for Q2 2021, filed 16 Aug 2021.